FDA Approved: HALOPERIDOL — Supplemental Application (Innogenix, Inc.)

View source ↗

Summary

FDA approved a supplemental application for HALOPERIDOL submitted by Innogenix, Inc., marking an approved update to the product through a supplemental filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia
• Tourette Syndrome

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL)